aid: abmtx
name: ABM Therapeutics
description: 'ABM Therapeutics (ABM) is a clinical-stage biopharmaceutical company founded
  in 2015, operating from San Diego, California and Zhangjiang, Pudong, Shanghai. It
  discovers and develops small-molecule targeted therapies for primary brain cancers
  including glioblastoma multiforme (GBM) and for brain metastases arising from melanoma,
  lung cancer and breast cancer. Its lead program, ABM-1310, is a brain-penetrant,
  selective BRAF V600 inhibitor that received US IND clearance in November 2019 and
  is in Phase 1 clinical study. ABM publishes no developer program, public API, SDK
  or machine-readable specification; its only public surface is a corporate, investor
  and clinical-news website. The company was surfaced through the API Evangelist harvest
  backlog from a secondary-market listing under the ticker-style slug "abmtx".'
image: http://www.abmtx.com/themes/basic/skin/images/icon_logo.jpg
url: https://raw.githubusercontent.com/api-evangelist/abmtx/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: profiled
x-tier-reason: enriched
specificationVersion: '0.20'
created: '2026-09-06'
modified: '2026-09-06'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Life Sciences
- Oncology
- Drug Discovery
- Clinical Trials
- Healthcare
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/abmtx-domain-security.yml
- type: LLMsTxt
  url: llms/abmtx-llms.txt
- type: Website
  url: http://www.abmtx.com/
- type: About
  url: http://www.abmtx.com/site/company
- type: Contact
  url: http://www.abmtx.com/site/contactus
- type: Newsroom
  url: http://www.abmtx.com/site/newscenter
- type: InvestorRelations
  url: http://www.abmtx.com/site/Investors
- type: LinkedIn
  url: https://www.linkedin.com/company/abm-therapeutics
- type: x-secondary-market-listing
  url: https://www.hiive.com/securities/abmtx-stock
x-enrichment:
  date: '2026-09-06'
  status: minimal
  artifacts_added: 3
  pass: local-v3
x-coverage:
  state: none
  reason: not-a-software-company
  detail: >-
    ABM Therapeutics is a clinical-stage biopharmaceutical company developing small-molecule
    brain-cancer drugs (lead program ABM-1310); its entire public surface is a PHP-CMS corporate
    and investor brochure at http://www.abmtx.com/ that serves no developer section, and no
    api./developer./developers./docs. subdomain for abmtx.com resolves at all.
  evidence:
  - url: http://www.abmtx.com/
    status: 200
  - url: http://www.abmtx.com/openapi.json
    status: 404
  - url: http://www.abmtx.com/llms.txt
    status: 404
  - url: http://www.abmtx.com/.well-known/api-catalog
    status: 404
  - url: http://abmtx.com/.well-known/agent-card.json
    status: 404
  checked: '2026-09-06'